Biotech

Latest Articles

Cassava pays for $40M over apparently confusing Alzheimer's update

.Cassava Sciences has consented to spend $40 million to solve an investigation right into claims it ...

Merck bags alternatives on Evaxion's AI-designed vaccination applicants

.Merck &amp Co. has gotten possibilities on pair of Evaxion Biotech vaccination candidates, spending...

Enanta's RSV antiviral crushes popular load in difficulty research study

.Enanta Pharmaceuticals has actually linked its respiratory syncytial virus (RSV) antiviral to signi...

Biogen cans SAGE-324 collaboration after important tremor fall short

.Biogen has conducted the last ceremonies to its own collaboration along with Sage Therapies on SAGE...

AbbVie Parkinson's medication from $8.7 B Cerevel purchase credit ratings

.On the very same day that some Parkinson's illness medications are actually being actually question...

Arch closes $3B-plus fund to cultivate biopharma upstarts

.On the heels of a $3 billion fund from Bain Capital Lifestyle Sciences, Arc Endeavor Partners is ac...

Orion to use Aitia's 'electronic identical twins' to discover brand-new cancer cells medications

.Finnish biotech Orion has actually spied possible in Aitia's "digital twin" technician to build bra...

Windtree's surprise med rears high blood pressure in newest period 2 succeed

.While Windtree Therapeutics has had a hard time to grow the monetary origins required to endure, a ...

2 cancer cells biotechs combine, generating worldwide impact

.OncoC4 is taking AcroImmune-- and its own internal professional manufacturing abilities-- under its...

Amgen reports very first stage 3 win for $400M chronic eczema drug

.Amgen has shared (PDF) the first stage 3 information on its own $400 thousand dermatitis drug, link...

Biogen, UCB document stage 3 lupus win after falling short earlier test

.Biogen and UCB's bank on developing into period 3 on the back of a broken study wants to have settl...

Aptadir really hopes new RNA inhibitors can reverse tricky cancers cells

.Italian biotech Aptadir Therapies has released along with the pledge that its pipe of preclinical R...

Wave surfs DMD results to regulators' doors, sending out stockpile

.Wave Life Sciences has actually satisfied its own goal in a Duchenne muscle dystrophy (DMD) study, ...

Sanofi plucks new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma layer, taking up th...

Achilles drops cell therapy system, braces for cutbacks after missing out on 'business practicality' targets

.Achilles Rehabs has actually wrecked its method. The English biotech is quiting working on its clin...

Aligos advertises period 2 MASH win, reducing liver body fat as much as 46%

.Aligos Therapeutics is declaring a midstage win in metabolic-dysfunction connected steatohepatitis ...

Basilea ratings $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work establishing brand new antifungals has actually acquired a significant...

Capricor markets Europe civil rights to late-stage DMD treatment for $35M

.Possessing currently gathered up the USA legal rights to Capricor Therapies' late-stage Duchenne mu...

FDA fragments adcomm for Applied's uncommon health condition drug

.After dismissing the decision date for Applied Therapies' metabolic condition drug govorestat, the ...

Novo inks $600M NanoVation package to examine genetic medicines ex-liver

.Novo Nordisk is continuing its own press right into hereditary medicines, agreeing to pay NanoVatio...